Company intelligence / Profile preview

Lofarma Allergeni

Milan, Lombardy, Italy
Ownership
Private
Employees
~150
Development stage
Other
01

Overview

Lofarma is an Italian pharmaceutical company specializing in the research, development, and production of allergen-specific immunotherapies and diagnostic tools. Founded in 1945 and based in Milan, the company is recognized for its innovation in the field of allergology, particularly for its patented monomeric allergoid technology. This technology, utilized in their flagship LAIS product line, allows for effective sublingual administration with a high safety profile. Lofarma's portfolio includes a wide range of treatments for respiratory and venom allergies, as well as comprehensive diagnostic kits for skin prick testing. The company operates its own manufacturing facilities in Italy and maintains a significant presence across Europe through various subsidiaries. As a private entity, Lofarma continues to focus on personalized medicine approaches to improve the quality of life for patients suffering from allergic diseases.

Therapeutic areas
ImmunologyOphthalmology
Modalities
BiologicImmunotherapy
Industry
Biotech

Beyond the preview

Go deeper on Lofarma Allergeni.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lofarma Allergeni.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call